Fortis Malar Hospitals Limited
Fortis Malar Hospitals Limited Fundamental Analysis
Fortis Malar Hospitals Limited (FORTISMLR.BO) shows moderate financial fundamentals with a PE ratio of 29.12, profit margin of 80.96%, and ROE of 12.81%. The company generates $0.0B in annual revenue with weak year-over-year growth of -1.00%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of -42.2/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze FORTISMLR.BO's fundamental strength across five key dimensions:
Efficiency Score
ExcellentFORTISMLR.BO demonstrates superior asset utilization.
Valuation Score
ModerateFORTISMLR.BO shows balanced valuation metrics.
Growth Score
WeakFORTISMLR.BO faces weak or negative growth trends.
Financial Health Score
ExcellentFORTISMLR.BO maintains a strong and stable balance sheet.
Profitability Score
WeakFORTISMLR.BO struggles to sustain strong margins.
Key Financial Metrics
Is FORTISMLR.BO Expensive or Cheap?
P/E Ratio
FORTISMLR.BO trades at 29.12 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, FORTISMLR.BO's PEG of 0.03 indicates potential undervaluation.
Price to Book
The market values Fortis Malar Hospitals Limited at 3.51 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 30.73 times EBITDA. This signals the market has high growth expectations.
How Well Does FORTISMLR.BO Make Money?
Net Profit Margin
For every $100 in sales, Fortis Malar Hospitals Limited keeps $80.96 as profit after all expenses.
Operating Margin
Core operations generate 49.04 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $12.81 in profit for every $100 of shareholder equity.
ROA
Fortis Malar Hospitals Limited generates $11.00 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Fortis Malar Hospitals Limited generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.
Free Cash Flow
Fortis Malar Hospitals Limited generates weak or negative free cash flow of $0.00, restricting financial flexibility.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
FORTISMLR.BO converts 0.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
29.12
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.03
vs 25 benchmark
P/B Ratio
Price to book value ratio
3.51
vs 25 benchmark
P/S Ratio
Price to sales ratio
1963.67
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.00
vs 25 benchmark
Current Ratio
Current assets to current liabilities
11.33
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.13
vs 25 benchmark
ROA
Return on assets percentage
0.11
vs 25 benchmark
ROCE
Return on capital employed
0.07
vs 25 benchmark
How FORTISMLR.BO Stacks Against Its Sector Peers
| Metric | FORTISMLR.BO Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 29.12 | 29.05 | Neutral |
| ROE | 12.81% | 746.00% | Weak |
| Net Margin | 8096.48% | -49773.00% (disorted) | Strong |
| Debt/Equity | 0.00 | 0.40 | Strong (Low Leverage) |
| Current Ratio | 11.33 | 4.00 | Strong Liquidity |
| ROA | 11.00% | -21585.00% (disorted) | Strong |
FORTISMLR.BO outperforms its industry in 4 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Fortis Malar Hospitals Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
-100.00%
Industry Style: Defensive, Growth, Innovation
DecliningEPS CAGR
104.43%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
609.50%
Industry Style: Defensive, Growth, Innovation
High Growth